62d ago

FDA Alignment De-Risks CalciMedica’s Auxora Path in AP

FDA aligns with $CALC on Auxora Phase 2b endpoints for acute pancreatitis, de-risking the path to registration. notreload.xyz/xy/fda-align... FDA aligns with CalciMedica on Auxora Phase 2b endpoints for acute pancreatitis, de-risking the path to registration.

1 reportother

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage

FDA Alignment De-Risks CalciMedica’s Auxora Path in AP

stream:bsky-jetstreamother62d ago kagi ↗

FDA aligns with $CALC on Auxora Phase 2b endpoints for acute pancreatitis, de-risking the path to registration. notreload.xyz/xy/fda-align... FDA aligns with CalciMedica on Auxora Phase 2b endpoints for acute pancreatitis, de-risking the path to registration.